CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Payment Arrangement, Expense, after Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Share-based Payment Arrangement, Expense, after Tax of $60.00 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2021-12-25 was $16.49M, a 24.15% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2021-09-25 was $18.87M, a 31.37% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2021-06-26 was $14.61M, a 30.99% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for the quarter ending 2021-03-27 was $11.20M, a 19.06% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for fiscal 2025 was $60.00M, a 1.00% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for fiscal 2024 was $59.40M, a 2.84% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for fiscal 2023 was $61.14M, a 2.41% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, expense, after tax for fiscal 2022 was $62.65M, a 2.41% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 6 month as first filed | Share-based Payment Arrangement, Expense, after Tax 9 month | Share-based Payment Arrangement, Expense, after Tax 9 month as first filed | Share-based Payment Arrangement, Expense, after Tax 12 month |
|---|---|---|---|---|---|---|
| 2025-12-27 | $60.00M 10-K · filed 2026-02-18 | |||||
| 2024-12-28 | $59.40M 10-K · filed 2026-02-18 | |||||
| 2023-12-30 | $61.14M 10-K · filed 2026-02-18 | |||||
| 2022-12-31 | $62.65M 10-K · filed 2025-02-19 | |||||
| 2021-12-25 | $16.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $35.36M derived: sum of 2 quarters · filed 2024-02-14 | $49.97M derived: sum of 3 quarters · filed 2024-02-14 | $61.17M 10-K · filed 2024-02-14 | ||
| 2021-09-25 | $18.87M 10-Q · filed 2021-11-03 | $33.48M derived: sum of 2 quarters · filed 2021-11-03 | $44.68M 10-Q · filed 2021-11-03 | $57.97M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-26 | $14.61M 10-Q · filed 2021-08-04 | $25.81M 10-Q · filed 2021-08-04 | $39.10M derived: sum of 3 quarters · filed 2023-02-22 | $53.46M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-27 | $11.20M 10-Q · filed 2021-05-04 | $24.49M derived: sum of 2 quarters · filed 2023-02-22 | $38.85M derived: sum of 3 quarters · filed 2023-02-22 | $50.00M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2020-12-26 | $13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $27.65M derived: sum of 2 quarters · filed 2023-02-22 | $38.80M derived: sum of 3 quarters · filed 2023-02-22 | $48.21M 10-K · filed 2023-02-22 | ||
| 2020-09-26 | $14.36M 10-Q · filed 2021-11-03 | $25.52M derived: sum of 2 quarters · filed 2021-11-03 | $34.93M 10-Q · filed 2021-11-03 | $46.37M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-06-27 | $11.15M 10-Q · filed 2021-08-04 | $20.56M 10-Q · filed 2021-08-04 | $32.01M derived: sum of 3 quarters · filed 2022-02-16 | $43.87M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-03-28 | $9.41M 10-Q · filed 2021-05-04 | $20.85M derived: sum of 2 quarters · filed 2022-02-16 | $32.71M derived: sum of 3 quarters · filed 2022-02-16 | $46.36M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2019-12-28 | $11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $23.30M derived: sum of 2 quarters · filed 2022-02-16 | $36.95M derived: sum of 3 quarters · filed 2022-02-16 | $47.81M 10-K · filed 2022-02-16 | ||
| 2019-09-28 | $11.86M 10-Q · filed 2020-10-29 | $25.51M derived: sum of 2 quarters · filed 2020-10-29 | $36.36M 10-Q · filed 2020-10-29 | $45.55M derived: sum of 4 quarters · filed 2021-02-17 | ||
| 2019-06-29 | $13.65M 10-Q · filed 2020-08-05 | $24.50M 10-Q · filed 2020-08-05 | $33.69M derived: sum of 3 quarters · filed 2021-02-17 | $43.14M derived: sum of 4 quarters · filed 2021-02-17 | ||
| 2019-03-30 | $10.85M 10-Q · filed 2020-05-07 | $20.04M derived: sum of 2 quarters · filed 2021-02-17 | $29.49M derived: sum of 3 quarters · filed 2021-02-17 | $40.59M derived: sum of 4 quarters · filed 2021-02-17 | ||
| 2018-12-29 | $9.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $18.64M derived: sum of 2 quarters · filed 2021-02-17 | $29.73M derived: sum of 3 quarters · filed 2021-02-17 | $38.16M 10-K · filed 2021-02-17 | ||
| 2018-09-29 | $9.45M 10-Q · filed 2019-11-06 | $20.54M derived: sum of 2 quarters · filed 2019-11-06 | $28.97M 10-Q · filed 2019-11-06 | $38.32M derived: sum of 4 quarters · filed 2020-02-11 | ||
| 2018-06-30 | $11.09M 10-Q · filed 2019-07-31 | $19.52M 10-Q · filed 2019-07-31 | $28.87M derived: sum of 3 quarters · filed 2020-02-11 | $36.30M derived: sum of 4 quarters · filed 2020-02-11 | ||
| 2018-03-31 | $8.43M 10-Q · filed 2019-05-07 | $17.78M derived: sum of 2 quarters · filed 2020-02-11 | $25.21M derived: sum of 3 quarters · filed 2020-02-11 | $32.82M derived: sum of 4 quarters · filed 2020-02-11 | ||
| 2017-12-30 | $9.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $16.78M derived: sum of 2 quarters · filed 2020-02-11 | $24.40M derived: sum of 3 quarters · filed 2020-02-11 | $30.57M 10-K · filed 2020-02-11 | ||
| 2017-09-30 | $7.43M 10-Q · filed 2017-11-09 | $15.04M derived: sum of 2 quarters · filed 2017-11-09 | $21.22M 10-Q · filed 2017-11-09 | $28.32M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-07-01 | $7.61M 10-Q · filed 2017-08-09 | $13.79M 10-Q · filed 2017-08-09 | $20.89M derived: sum of 3 quarters · filed 2019-02-13 | $27.71M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-04-01 | $6.18M 10-Q · filed 2017-05-10 | $13.28M derived: sum of 2 quarters · filed 2019-02-13 | $20.09M derived: sum of 3 quarters · filed 2019-02-13 | $27.84M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2016-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $13.91M derived: sum of 2 quarters · filed 2019-02-13 | $21.67M derived: sum of 3 quarters · filed 2019-02-13 | $28.09M 10-K · filed 2019-02-13 | ||
| 2016-09-24 | $6.82M 10-Q · filed 2017-11-09 | $14.57M derived: sum of 2 quarters · filed 2017-11-09 | $20.99M 10-Q · filed 2017-11-09 | $27.28M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-25 | $7.75M 10-Q · filed 2017-08-09 | $14.18M 10-Q · filed 2017-08-09 | $20.46M derived: sum of 3 quarters · filed 2018-02-13 | $27.21M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-26 | $6.43M 10-Q · filed 2017-05-10 | $12.71M derived: sum of 2 quarters · filed 2018-02-13 | $19.45M derived: sum of 3 quarters · filed 2018-02-13 | $26.04M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-26 | $6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $13.03M derived: sum of 2 quarters · filed 2018-02-13 | $19.61M derived: sum of 3 quarters · filed 2018-02-13 | $25.90M 10-K · filed 2018-02-13 | ||
| 2015-09-26 | $6.74M 10-Q · filed 2016-11-02 | $13.32M derived: sum of 2 quarters · filed 2016-11-02 | $19.61M 10-Q · filed 2016-11-02 | $24.78M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-06-27 | $6.58M 10-Q · filed 2016-08-03 | $12.87M 10-Q · filed 2016-08-03 | $18.04M derived: sum of 3 quarters · filed 2017-02-14 | $23.34M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-03-28 | $6.29M 10-Q · filed 2016-05-04 | $11.46M derived: sum of 2 quarters · filed 2017-02-14 | $16.77M derived: sum of 3 quarters · filed 2017-02-14 | $22.02M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2014-12-27 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $10.48M derived: sum of 2 quarters · filed 2017-02-14 | $15.73M derived: sum of 3 quarters · filed 2017-02-14 | $20.03M 10-K · filed 2017-02-14 | ||
| 2014-09-27 | $5.31M 10-Q · filed 2015-11-04 | $10.57M derived: sum of 2 quarters · filed 2015-11-04 | $14.86M 10-Q · filed 2015-11-04 | $18.94M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-28 | $5.26M 10-Q · filed 2015-07-30 | $9.55M 10-Q · filed 2015-07-30 | $13.63M derived: sum of 3 quarters · filed 2016-02-12 | $17.57M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-29 | $4.29M 10-Q · filed 2015-04-30 | $8.37M derived: sum of 2 quarters · filed 2016-02-12 | $12.31M derived: sum of 3 quarters · filed 2016-02-12 | $16.32M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-28 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $8.02M derived: sum of 2 quarters · filed 2016-02-12 | $12.02M derived: sum of 3 quarters · filed 2016-02-12 | $15.88M 10-K · filed 2016-02-12 | ||
| 2013-09-28 | $3.94M 10-Q · filed 2014-10-30 | $7.95M derived: sum of 2 quarters · filed 2014-10-30 | $11.81M 10-Q · filed 2014-10-30 | $11.81M 10-Q · filed 2013-10-30 | $15.66M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-06-29 | $4.00M 10-Q · filed 2014-08-07 | $7.87M 10-Q · filed 2014-08-07 | $7.87M 10-Q · filed 2013-07-31 | $11.71M derived: sum of 3 quarters · filed 2015-02-17 | $15.11M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-03-30 | $3.86M 10-Q · filed 2014-04-30 | $7.71M derived: sum of 2 quarters · filed 2015-02-17 | $11.10M derived: sum of 3 quarters · filed 2015-02-17 | $14.54M derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2012-12-29 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $7.24M derived: sum of 2 quarters · filed 2015-02-17 | $10.68M derived: sum of 3 quarters · filed 2015-02-17 | $14.06M 10-K · filed 2015-02-17 | ||
| 2012-09-29 | $3.39M 10-Q · filed 2013-10-30 | $6.83M derived: sum of 2 quarters · filed 2013-10-30 | $10.21M 10-Q · filed 2013-10-30 | $13.27M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $3.44M 10-Q · filed 2013-07-31 | $6.82M 10-Q · filed 2013-07-31 | $9.87M derived: sum of 3 quarters · filed 2014-02-25 | $13.45M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $3.38M 10-Q · filed 2013-05-08 | $6.43M derived: sum of 2 quarters · filed 2014-02-25 | $10.02M derived: sum of 3 quarters · filed 2014-02-25 | $13.51M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $6.63M derived: sum of 2 quarters · filed 2014-02-25 | $10.12M derived: sum of 3 quarters · filed 2014-02-25 | $13.92M 10-K · filed 2014-02-25 | ||
| 2011-09-24 | $3.58M 10-Q · filed 2012-11-01 | $7.07M derived: sum of 2 quarters · filed 2012-11-01 | $10.87M 10-Q · filed 2012-11-01 | $13.53M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-06-25 | $3.49M 10-Q · filed 2012-08-07 | $7.29M 10-Q · filed 2012-08-07 | $9.95M derived: sum of 3 quarters · filed 2013-02-27 | $14.28M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-26 | $3.80M 10-Q · filed 2012-05-04 | $6.46M derived: sum of 2 quarters · filed 2013-02-27 | $10.79M derived: sum of 3 quarters · filed 2013-02-27 | $15.70M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2010-12-25 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $6.99M derived: sum of 2 quarters · filed 2013-02-27 | $11.90M derived: sum of 3 quarters · filed 2013-02-27 | $16.35M 10-K · filed 2013-02-27 | ||
| 2010-09-25 | $4.33M 10-Q · filed 2011-11-02 | $9.24M derived: sum of 2 quarters · filed 2011-11-02 | $13.68M 10-Q · filed 2011-11-02 | |||
| 2010-06-26 | $4.91M 10-Q · filed 2011-08-03 | $9.29M 10-Q · filed 2011-08-03 | ||||
| 2009-12-26 | $15.26M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |